US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agile Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023 ↗
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Agile Therapeutics: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Agile Therapeutics's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Agile Therapeutics's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Why Agile Therapeutics (AGRX) Stock Is Down 60% ↗
Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its trading on the Nasdaq effective Tuesday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Agile Therapeutics Announces Delisting from Nasdaq
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 22, 2024 ↗
Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million. 
Via Benzinga
News headline image
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
Live Conference Call and Webcast at 8:30 a.m. ET 
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
Live Conference Call and Webcast at 8:30 a.m. ET 
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Elimination of Remaining Debt to Perceptive Advisors Leaves the Company’s Balance Sheet Debt Free 
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Etsy, Inc. 
Via Benzinga
News headline image
What's Going On With Women Health Focused Agile Therapeutics Stock Today? ↗
Agile Therapeutics stock rises on premarket trading, exercising warrants for $4.8M gross proceeds with reduced exercise price of $1.25 per share. 
Via Benzinga
News headline image
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Is Bel Fuse (BELFB) Stock Down 17% Today? ↗
Bel Fuse stock is falling on Thursday as investors in BELFB shares react to the company's lackluster Q4 2023 earnings report. 
Via InvestorPlace
News headline image
Why Is Draganfly (DPRO) Stock Down 48% Today? ↗
Draganfly stock is down on Thursday after the company announced details for a $3.6 million public offering of DPRO shares. 
Via InvestorPlace
News headline image
Why Is BuzzFeed (BZFD) Stock Up 101% Today? ↗
BuzzFeed stock is rising higher on Thursday as investors in BZFD react to it selling Complex for $108.6 million in cash. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today? ↗
Agile Therapeutics stock is rising higher on Thursday with heavy trading of AGRX shares despite a lack of news from the company. 
Via InvestorPlace
News headline image
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning! 
Via InvestorPlace
News headline image
5 Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
From Agile Therapeutics, Inc.
Via GlobeNewswire
News headline image
A Look Into Healthcare Sector Value Stocks ↗
 
Via Benzinga
News headline image
Overview Of Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >